Multiple Sclerosis
|
0.440 |
GeneticVariation
|
disease |
GWASCAT |
Overexpression of the Cytokine BAFF and Autoimmunity Risk.
|
28445677 |
2017 |
Multiple Sclerosis
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
Replication extended to the following polymorphisms: PKN2 (rs305217), GTF2B (rs7538427), EPHA4 (rs1517440), YTHDF3 (rs12115114), ANKFN1 (rs17758761) and PTPRM (rs4798571), which did not reach the threshold of significance in a follow-up of the first genome-wide association study (GWAS) conducted in multiple sclerosis; TMEM39A (rs1132200), which appeared as a newly identified susceptibility gene in the same study; a gene previously reaching GWAS significance in Italy, CBLB (rs9657904); IL12B (rs6887695, rs10045431), a susceptibility gene shared by diverse autoimmune diseases and, finally, another gene showing inconclusive association with multiple sclerosis, CNR1 (rs1049353).
|
22194214 |
2012 |
Multiple Sclerosis
|
0.440 |
AlteredExpression
|
disease |
BEFREE |
These data link expression of FOXP3, CBLB and ITCH mRNA and CTLA-4 expression on the surface of CD4(+) CD25(high) T cell in MS. We hypothesize that this may reflect alterations in the inhibitory effect of CTLA-4 or in regulatory T cell function.
|
23039885 |
2012 |
Multiple Sclerosis
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
These data provide further evidence of the association of MS disease with variation within CBLB.
|
21037273 |
2011 |
Multiple Sclerosis
|
0.440 |
Biomarker
|
disease |
BEFREE |
CBLB encodes a negative regulator of adaptive immune responses, and mice lacking the ortholog are prone to experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis.
|
20453840 |
2010 |
Multiple Sclerosis
|
0.440 |
GeneticVariation
|
disease |
GWASCAT |
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.
|
20453840 |
2010 |
Multiple Sclerosis
|
0.440 |
GeneticVariation
|
disease |
GWASDB |
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.
|
20453840 |
2010 |
Multiple Sclerosis
|
0.440 |
Biomarker
|
disease |
CTD_human |
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.
|
20453840 |
2010 |
Leukemia, Myelocytic, Acute
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
In summary, novel mutations in c-CBL and CBL-b have been identified in human AML and may represent potential targets for novel therapeutics.
|
17475912 |
2007 |
Leukemia, Myelocytic, Acute
|
0.310 |
GeneticVariation
|
disease |
LHGDN |
In summary, novel mutations in c-CBL and CBL-b have been identified in human AML and may represent potential targets for novel therapeutics.
|
17475912 |
2007 |
Leukemia, Myelocytic, Acute
|
0.310 |
CausalMutation
|
disease |
CGI |
|
|
|
Experimental Autoimmune Encephalomyelitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
CBLB encodes a negative regulator of adaptive immune responses, and mice lacking the ortholog are prone to experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis.
|
20453840 |
2010 |
Multiple Sclerosis, Acute Fulminating
|
0.300 |
Biomarker
|
disease |
CTD_human |
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.
|
20453840 |
2010 |
Diabetes Mellitus, Insulin-Dependent
|
0.250 |
Biomarker
|
disease |
BEFREE |
The interaction between UBASH3A and CBL-B may synergistically inhibit T cell function and affect risk for type 1 diabetes, as both genes have been shown to be associated with this autoimmune disease.
|
31659016 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
0.250 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, evidence of a statistical interaction with the known T1D susceptibility-associated CTLA4 polymorphism rs3087243 (laboratory name CT60, G>A) was reported (P<0.0001), such that the CBLB SNP rs3772534 G allele was overtransmitted to offspring with the CTLA4 rs3087243 G/G genotype.
|
17209142 |
2007 |
Diabetes Mellitus, Insulin-Dependent
|
0.250 |
GeneticVariation
|
disease |
BEFREE |
One SNP in exon 12 of the CBLB gene was significantly demonstrated to be associated to T1D in a large Danish T1D family material of 480 families.
|
15629882 |
2005 |
Diabetes Mellitus, Insulin-Dependent
|
0.250 |
GeneticVariation
|
disease |
BEFREE |
Evaluation of disease association by a multilocus transmission/disequilibrium test (TDT) gave a P value of 0.484 for IAN4L1 and 0.692 for CBLB, suggesting that neither gene influences susceptibility to common alleles of human type 1 diabetes in these populations.
|
14747305 |
2004 |
Diabetes Mellitus, Insulin-Dependent
|
0.250 |
GeneticVariation
|
disease |
BEFREE |
Seven single-nucleotide polymorphism (SNP) markers spanning the CBLB gene were genotyped in multiplex T1D families and assessed for disease association by transmission disequilibrium testing.
|
14961073 |
2004 |
Diabetes Mellitus, Insulin-Dependent
|
0.250 |
SusceptibilityMutation
|
disease |
RGD |
Cblb is a major susceptibility gene for rat type 1 diabetes mellitus.
|
12118252 |
2002 |
Diabetes Mellitus, Insulin-Dependent
|
0.250 |
Biomarker
|
disease |
RGD |
Cblb is a major susceptibility gene for rat type 1 diabetes mellitus.
|
12118252 |
2002 |
Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A catalog of genetic loci associated with kidney function from analyses of a million individuals.
|
31152163 |
2019 |
Hypothyroidism
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Autoimmune Diseases
|
0.090 |
Biomarker
|
group |
BEFREE |
The interaction between UBASH3A and CBL-B may synergistically inhibit T cell function and affect risk for type 1 diabetes, as both genes have been shown to be associated with this autoimmune disease.
|
31659016 |
2019 |
Autoimmune Diseases
|
0.090 |
Biomarker
|
group |
BEFREE |
The CBLB protein (CBL-B) is a key regulator of peripheral immune tolerance by limiting T cell activation and expansion and hence T cell-mediated autoimmunity through its ubiquitin E3-ligase activity.
|
25261476 |
2014 |
Autoimmune Diseases
|
0.090 |
Biomarker
|
group |
BEFREE |
Understanding the signaling pathways regulated by Cbl-b in innate and adaptive immune cells is therefore essential for efficient manipulation of Cbl-b in emerging immunotherapies for human disorders such as autoimmune diseases, allergic inflammation, infections, and cancer.
|
24875217 |
2014 |